ABSTRACT
introduction
Local infiltration analgesia (LIA) following total knee arthroplasty (TKA) reduces the need for postoperative opioid analgesia and its associated risks. [1] [2] [3] [4] LIA also reduces the length of hospital stay and cost of public health services. In Australia, 48 502 TKAs were performed in 2012, 5 with a 5.5% increase per year. This study compared the outcome and cost following LIA versus standard analgesia in TKA.
MATERIALS AND METHODS
The study was approved as a quality assurance/ clinical audit by the North Coast New South Wales Human Research Ethics Committee. 13 men and 33 women (mean age, 67.5 years) underwent TKA between August 2010 and April 2013 by a single surgeon and received LIA (n=24) or standard analgesia (n=22), depending on the availability of the senior anaesthetist. Patients with a history of deep venous thrombosis or pulmonary embolism or on long-term warfarin therapy were excluded from the LIA group. Patients undergoing a bilateral or revision procedure, with an intra-operative fracture, or with a history of rheumatoid or inflammatory disease were excluded from the study.
A medial parapatellar approach was used. A tourniquet was applied until compression bandaging. Cruciate-retaining, fixed-bearing, and cemented components were used. The patella was resurfaced when arthritis was of Outerbridge grade 4.
In the LIA group, spinal anaesthesia was used in all 24 patients by the senior anaesthetist. In the standard analgesia group, 11 patients each received spinal or general anaesthesia, together with ultrasound-guided femoral and sciatic nerve blocks and use of a femoral nerve catheter. In 5 of the patients, patient-controlled analgesia was given instead of the femoral nerve catheter, as decided by the anaesthetist in charge.
In the LIA group, intra-articular anaesthetic mixture was injected intra-operatively. The mixture comprised ropivocaine hydrochloride 2.0 mg/ml, ketorolac tromethamine 30 mg, and adrenaline 10 µg/ml diluted with normal saline to 150 ml such that the total dose did not exceed 300 mg. 1 The total dose of ropivocaine was reduced to 250 mg if the patient was unusually small (<55 kg), old (>85 years), infirm (American Society of Anesthesiologists score of 3 or 4), or intolerant to anaesthetic or analgesic agents. If non-steroidal anti-inflammatory drugs were contra-indicated, ketorolac was omitted. 50 ml of the mixture was first injected into the posterior capsule after bone cutting prior to implant insertion. The remainder was injected throughout the various soft tissue layers prior to wound closure. Immediately before wound closure, a needle was inserted from within the suprapatellar pouch laterally and out through the skin to a point approximately 10 cm lateral to the incision. A catheter was then passed through the needle and the needle withdrawn. The catheter was placed in the lateral gutter of the knee joint with the tip connected to a bacterial filter and flushed with 1 ml of mixture to ensure patency. The wound was then closed in layers and adhesive dressings applied. The catheter and filter were secured to the skin with an adhesive dressing. Compression bandages were then applied. In the standard anaesthesia group, intra-articular anaesthesia was not used, and a deep suction drain was inserted.
Postoperatively, in the LIA group, a buprenorphine 5 µg topical patch and regular paracetamol or paracetamol 665 mg + codeine 30 mg were given. Oral celecoxib 200 mg was also given twice daily unless contraindicated. Oral oxycodone hydrochloride was given as patients required. According to the LIA protocol, when the pain score was >4 out of 10, bupivacaine 0.5% with adrenaline 15 ml was given through the LIA catheter within 6 hours of TKA. More than 6 hours after TKA, additional ketoralac 10 mg/ml per 1 ml was also given. On day 1, bupivacaine 0.5%, adrenaline 30 ml, and ketoralac 10 mg/ml per 1 ml were given and the catheter removed. In the standard analgesia group, regular panadol or panadol osteo was given. In patients with a femoral nerve catheter, a continuous infusion of 0.2% or 0.75% ropivocaine for 24 to 48 hours was given. In the 5 patients with patient-controlled analgesia, intravenous endone or fentanyl was given. Oral endone was given as patients required. When a large endone dose was required, regular slow-acting oxycodone hydrochloride was prescribed.
Both groups received aspirin 300 mg daily for 6 weeks as standard thromboprophylaxis. Patients in the standard analgesia group received subcutaneous enoxaparin 40 mg daily before discharge. For physiotherapy (straight leg raise, inner range quadriceps exercises, sitting on the edge of the bed, and mobility with a walking aid), the first session commenced 4 hours after TKA for the LIA group and on day 1 for the standard analgesia group.
Outcome measures included range of motion, ability to straight leg raise, pain, length of hospital stay, costs, and complications. The Chi-square and Fisher Exact tests were used for binary outcome measures. Repeated measures analysis of variance (RMAV), using PROC GLM, was used to assess pain and range of motion over time where the time by group interaction indicates a difference over time between groups.
results
The 2 groups were comparable at baseline in terms of age, gender, body mass index, American Society of Anesthesiologists score, and range of motion (Table  1) . Compared with the standard analgesia group, the LIA group resulted in a shorter mean length of hospital stay (4.9 vs. 2.7 days, p<0.0001) and higher proportion of patients able to straight leg raise on discharge (38% vs. 86%, p=0.0011), as well as lower pain scores in the first 3 days and greater range of motion at all time points (but not significantly on discharge or at week 6) [ Respectively in the standard analgesia and LIA groups, the mean cost per patient for all analgesic medication was A$129.25 and A$153.63, the mean cost per patient for all nights spent in hospital was A$1600.36 and A$901.50, and thus the mean total cost per patient was A$1729.61 and A$1055.13. The cost of intravenous analgesic administered via the LIA catheter ranged from A$104.07 to A$173.46, depending on the amount of top up ( Table 2 ). The standard analgesia group required more oral opioid analgesia, which was relatively inexpensive. The cost of a night spent in hospital (inclusive of nursing and physiotherapy costs) was A$326.
Two patients in each group had a superficial wound infection, which was resolved with intravenous or oral antibiotics. One patient in each group had a leak from the femoral nerve catheter or the LIA catheter; both catheters were removed. One patient in the standard analgesia group required urgent fluid resuscitation for hypotension and hypoperfusion.
discussion
In a study of 86 patients who received LIA for TKA, 51% were discharged after one overnight stay in hospital, with a mean length of hospital stay of 3.2 days and a mean of 13 hours to first mobilisation and 20 hours to independent mobility. 1 Pain was worst at approximately 4 hours after TKA. 1 The rate of local infection around catheter sites is low (0-3.2%), and the rate of bacterial colonisation of peripheral nerve catheters is quite high (7.5-57%), depending on the location and the number of colonies used to determine colonisation. 6 Although the LIA catheter is intra-articular, it has not been reported to be associated with deep infection of the joint.
One limitation of our study was that the 2 groups were not randomised, but their baseline characteristics were comparable. In addition, patients in the LIA group were encouraged to mobilise on the day of surgery; the effect of pre-education may have accelerated the time to independent mobility. conclusion LIA effectively controls pain, improves physiotherapy outcome, and reduces hospital costs in patients undergoing TKA.
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